Owl Creek Asset Management’s Japer Therapeutics Warrants JSPRW Stock Holding History
Bought
Maintained
Sold
Other funds holding JSPRW
CAC
ICM
TCM
HCM
CL
ZA
EPM
Owl Creek Asset Management's JSPRW Position: Q1 2023 in Review
Owl Creek Asset Management sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2023, closing a stake of 267,189 shares — an estimated $8.02K sold.
Owl Creek Asset Management first reported a position in JSPRW in Q1 2020 and held it in 12 quarters. The position peaked at $995K in Q3 2021. 10 funds tracked by Wall St. Rank hold JSPRW as of Q1 2023.
- Owl Creek Asset Management reported no remaining Japer Therapeutics Warrants position as of Q1 2023 after selling out during the quarter.
- Owl Creek Asset Management sold 267,189 Japer Therapeutics Warrants shares in Q1 2023, an estimated $8.02K.
- Owl Creek Asset Management first reported a position in Japer Therapeutics Warrants in Q1 2020 and held it in 12 quarters.
- Owl Creek Asset Management's Japer Therapeutics Warrants position peaked at $995K in Q3 2021.
- 10 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2023.
Based on Owl Creek Asset Management's 13F filing for Q1 2023, filed 15 May 2023.